[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"blood-transfusion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:blood-transfusion":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,50,74,102,144,168,209,239,274],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100644603","personalized-blood-transfusion-protocol-for-cardiac-patients-100644603",false,"NCT07671469","Personalized Blood Transfusion Protocol for Cardiac Patients","Personalized (Demand-Informed) Blood Transfusion Protocol for Cardiac Patients","PerP","Inclusion Criteria:\n\n* Adults 18 years or older scheduled for cardiac surgery using the heart-lung machine (cardiopulmonary bypass), such as bypass, valve, or combined procedures\n* Moderate-to-high surgical risk (e.g., EuroSCORE II ≥ 3% or equivalent)\n* Allogeneic red blood cell transfusion is considered likely\n* Able to provide informed consent and understand randomization to different transfusion thresholds\n* Willing to receive blood products and follow study transfusion thresholds from anesthesia induction until hospital discharge or day 28, whichever comes first\n\nExclusion Criteria:\n\n* Refusal of or contraindication to allogeneic blood (e.g., Jehovah's Witness or formal directive against transfusion), or enrollment in a preoperative autologous donation program\n* Emergency or salvage procedures where protocol triggers are impractical (e.g., active arrest, aortic dissection with collapse)\n* Heart transplantation, durable ventricular assist device implantation, or surgery solely for VAD insertion\n* Off-pump bypass or other procedures not using cardiopulmonary bypass\n* Severe preoperative anemia (e.g., hemoglobin \\\u003C 8 g\u002FdL) or chronic transfusion-dependent anemia\n* Conditions preventing protocol adherence (e.g., anticipated massive hemorrhage, known bleeding disorder, very low platelets, uninterruptible dual antiplatelet\u002Fanticoagulant therapy)\n* Chronic dialysis dependence or established end-stage renal disease (eGFR \\\u003C 15 mL\u002Fmin\u002F1.73m² or on maintenance renal replacement therapy) prior to surgery.\n* Pregnancy or lactation\n* Enrollment in another interventional trial affecting transfusion practice or hemoglobin thresholds\n* Unable to provide informed consent (e.g., severe cognitive impairment without a legally authorized representative)","ALL","18 Years",{"count":20,"type":21},900,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study compares two accepted ways of deciding when adults recovering from open-heart surgery should receive a blood transfusion in the intensive care unit. One approach gives a transfusion when the blood count (hemoglobin) falls below a fixed level that is the same for everyone. The other approach adds each patient's own physiology - such as oxygen levels and lactate - to help decide whether a transfusion is truly needed, within a safe range. The investigators want to learn whether the personalized approach is as safe as the standard approach for major outcomes after heart surgery, while reducing the amount of blood transfused. Participants may also choose to give blood and stool samples to a research biobank for future studies on recovery after cardiac surgery.",[27,28,29,30],"Cardiac Surgery","Blood Transfusion","Anemia","Cardiopulmonary Bypass",[32,33,34,35,36],"restrictive transfusion","hemoglobin trhreshold","oxygen delivery","cardiac surgery","ICU","NOT_YET_RECRUITING","2026-06-26",{"date":40,"type":41},"2026-06-30","ACTUAL",{"date":43,"type":21},"2026-09-14",{"date":45,"type":21},"2030-03-15",{"name":47,"class":48},"Yan Mia Min","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":22,"phases":60,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":73},"100523967","oxygen-extraction-guided-transfusion-100523967","NCT06102590","Oxygen Extraction-guided Transfusion","Oxygen Extraction-guided Transfusion Strategy in Critically Ill Patients. A Randomized Controlled Trial.","OXYTRIP","Inclusion Criteria:\n\n* Hb levels ≤ 9.0 g\u002FdL (as confirmed through a blood test and\u002For through blood gas analysis)\n* Presence of an arterial line and a central venous line (either jugular or subclavian), with confirmed correct position of the catheter tip at the atrio-caval junction (allowing correct estimation of central venous saturation, ScvO2).\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years;\n* Pregnancy\n* Clinical evidence of acute bleeding\n* Diagnosis of haematological malignancy\n* Diagnosis of sickle cell disease, or other diseases exposing the patient to chronic RCBTs\n* Acquired or congenital disorders of coagulation\n* Patients with ongoing AKI of stage 1 or worse and\u002For known chronic kidney disease (CKD) of stage G3a or worse, defined as glomerular filtration rate below 60 for a minimum of 3 months",{"count":59,"type":21},324,[24],"In critically ill patients, optimized strategies for red blood cells transfusion (RBCT) are still controversial. Most recent guidelines suggest that clinical practice in ICU setting should follow a restrictive approach to RBCT (i.e., hemoglonim level \\\u003C 7.0 g\u002FdL).In our previous study, oxygen extraction ratio (O2ER) has shown good performance as a marker to identify the correct timing for RBCT, potentially affecting 90-day mortality in non-bleeding, critically ill patients \\[11\\]. Moreover, our data suggested that an individualized strategy for RBCT may reduce the incidence of acute kidney injury (AKI), which is possibly related to a better delivery of oxygen and organ perfusion.",[28],"RECRUITING","2026-04-27",{"date":66,"type":41},"2026-05-01",{"date":68,"type":41},"2023-11-04",{"date":70,"type":21},"2027-01-01",{"name":72,"class":48},"Università degli Studi di Ferrara",4,{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":82,"sex":17,"minAge":18,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":87,"conditions":88,"keywords":90,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":49},"100635875","donor-lifestyle-and-nutritional-status-blood-component-quality-and-patient-safety-esencia-100635875","NCT07558369","Donor Lifestyle and Nutritional Status, Blood Component Quality, and Patient Safety (ESENCIA)","Lifestyle of Blood Donors and Its Impact on the Quality of Blood Components During Storage and Patient Safety","ESENCIA","Inclusion Criteria:\n\n* Eligible candidates according to Mexican regulatory standards for blood donation (NOM-253-SSA1-2012)\n\nExclusion Criteria:\n\n\\- Refusal to provide specific informed consent for participation in the research",true,"64 Years",{"count":85,"type":21},1014,"OBSERVATIONAL","The goal of this observational study is to evaluate how blood donors' lifestyle and nutritional status influence the quality of packed red blood cells (pRBCs) during storage and their impact on patient safety in transfused neonates and postpartum women. The main questions it aims to answer are:\n\n1. Are donor lifestyle and nutritional profiles associated with the development of storage lesions in pRBCs?\n2. Do these donor-related factors influence clinical outcomes after transfusion in neonates and postpartum women?\n3. Are storage lesion in pRBCs associated with clinical outcomes in transfused neonates and postpartum women?\n\nResearchers will compare pRBC units stratified according to donor lifestyle and nutritional profiles to determine differences in storage lesion biomarkers and post-transfusion clinical outcomes.",[89,28],"Blood Donation",[28,91],"Storage Lesions","2026-04-23",{"date":94,"type":41},"2026-04-30",{"date":96,"type":21},"2026-07",{"date":98,"type":21},"2029-07",{"name":100,"class":101},"Instituto Nacional de Perinatologia","OTHER_GOV",{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":4,"eligibilityCriteria":108,"healthyVolunteers":11,"sex":17,"minAge":109,"maxAge":110,"enrollmentInfo":111,"targetDuration":4,"studyType":22,"phases":113,"briefSummary":114,"conditions":115,"keywords":124,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":49},"100631599","heterologous-cord-blood-derived-red-blood-cell-for-transfusion-in-extremely-preterm-infants-100631599","NCT07502781","Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants","Multicenter, Randomized, Double-Blind Pilot Clinical Trial Evaluating the Impact of Transfusion With Heterologous Cord Blood-Derived Red Blood Cells Versus Adult Red Blood Cells in Extremely Premature Infants","Inclusion Criteria:\n\n* Signed informed consent obtained from parents or legal guardians.\n* Gestational age at birth \\\u003C 28 weeks or birth weight \\\u003C 1000 g.\n* Admission to one of the participating neonatal intensive care units (NICUs) in the Barcelona area.\n\nExclusion Criteria:\n\n* Prior red blood cell transfusion during the fetal or neonatal period.\n* Maternal-fetal immunization (e.g., isoimmunization).\n* Fetal hydrops.\n* Major congenital malformations.\n* Congenital infections.\n* Immediate need for blood before randomization (e.g., hemorrhagic shock, consumptive coagulopathy).\n* Participation in another clinical trial that could interfere with the primary outcome.","23 Weeks","28 Weeks",{"count":112,"type":21},176,[24],"Anemia is a condition in which there are not enough red blood cells to carry oxygen throughout the body. It is very common in extremely preterm infants (born before 28 weeks of pregnancy), and many of these babies require red blood cell transfusions during their hospital stay.\n\nCurrently, transfusions are given using red blood cells donated by adults. An alternative option is to use red blood cells collected from umbilical cord blood, which may be more similar to a newborn's own blood. This approach has been used in some neonatal units with encouraging results and no reported safety concerns.\n\nThis study aims to determine whether transfusion with umbilical cord blood improves clinical outcomes and reduces potential side effects compared to standard adult donor blood transfusion in extremely preterm infants. We hypothesize that umbilical cord blood transfusion will be at least as safe as adult donor blood and may provide clinical benefits.\n\nAbout 115 extremely preterm infants admitted to neonatal units in Catalonia will participate. If parents agree, their baby will be randomly assigned to receive either compatible umbilical cord blood or compatible adult donor blood if a transfusion becomes necessary. Babies will only receive a transfusion if they clinically need one. If cord blood is not available at the time of transfusion, the baby will receive compatible adult donor blood regardless of the assigned group.\n\nTo evaluate the response to treatment, small blood samples will be collected at birth, at one month of life, and 24 hours after any transfusion. These samples are taken at the same times as routine blood tests, so participation does not require additional needle sticks. The amount of blood collected is minimal (about 0.2 mL per sample).\n\nIn addition, a painless and non-invasive sensor will be placed on the baby's head for 24 hours to measure oxygen delivery to the brain. Urine samples will also be collected before and after transfusion to help assess how oxygen reaches body tissues.\n\nParticipation will continue until the baby reaches 36 weeks of postmenstrual age or is discharged from the hospital, whichever comes first.",[116,117,28,118,119,120,121,122,123],"Extremely Premature Infant","Anemia Neonatal","Umbilical Cord Blood","Fetal Hemoglobin","Bronchopulmonary Dysplasia (BPD)","Retinopathy of Prematurity (ROP)","Death; Neonatal","Intensive Care Units, Neonatal",[125,126,127,128,129,130,131,132,133,134],"Cord blood red blod cell transfusion","Umbilical cord blood transfusion","Extremely preterm infants","Neonatal anemia","Fetal hemoglobin","Adult donor red blood cells","Bronchopulmonary dysplasia","Retinopathy of prematurity","Oxygen delivery","Days requiring oxygen supplementation","2026-03-27",{"date":137,"type":41},"2026-03-31",{"date":139,"type":21},"2027-01",{"date":141,"type":21},"2029-12",{"name":143,"class":48},"Hospital Clinic of Barcelona",{"id":145,"slug":146,"hasResults":11,"nctId":147,"briefTitle":148,"officialTitle":149,"acronym":4,"eligibilityCriteria":150,"healthyVolunteers":11,"sex":17,"minAge":151,"maxAge":152,"enrollmentInfo":153,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":155,"conditions":156,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":159,"lastUpdatePostDateStruct":160,"startDateStruct":162,"completionDateStruct":164,"leadSponsor":166,"locationsCount":49},"100571530","modeling-blood-management-and-hemolytic-risk-in-pediatric-heart-surgery-100571530","NCT06721455","Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery","Mathematical Modeling of Salvaged Red Blood Cells-based Blood Management Strategy and Their Hemolytic Risk in Pediatric Cardiac Surgery","Inclusion Criteria:\n\n* pediatric patients under 18 years of age undergoing cardiac surgery with clear prime on cardio-pulmonary bypass (CPB) at Boston Children's Hospital (BCH).\n\nExclusion Criteria:\n\n* patients with known hemolytic disorders, patients on nitric oxide preoperatively, and patients found to have abnormal coagulation on routine preoperative assessment. Patients receiving heparin, American Society of Anesthesia (ASA) status, apixaban, warfarin, or bivalirudin held appropriately (i.e. for elective surgery) will not be excluded","0 Years","17 Years",{"count":154,"type":21},50,"This study aims to learn more about blood management in children undergoing heart surgery, such as the right amounts, and the best blood products, to administer. It also aims to develop a mathematical model that may help researchers better predict and treat patients who need blood transfusions during heart surgery.",[157,28,158],"Heart Surgery","Hemolysis","2026-01-05",{"date":161,"type":41},"2026-01-07",{"date":163,"type":41},"2025-08-01",{"date":165,"type":21},"2026-12-31",{"name":167,"class":48},"Boston Children's Hospital",{"id":169,"slug":170,"hasResults":11,"nctId":171,"briefTitle":172,"officialTitle":173,"acronym":174,"eligibilityCriteria":175,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":176,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":178,"conditions":179,"keywords":188,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":199,"lastUpdatePostDateStruct":200,"startDateStruct":202,"completionDateStruct":204,"leadSponsor":206,"locationsCount":208},"100616764","hip-fracture-surgery-timing-and-blood-transfusion-risk-in-patients-on-doacs-100616764","NCT07309848","Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs","Blood Transfusion Risk After Early vs. Delayed Surgery in Hip Fracture Patients on Direct Oral Anticoagulants: A Natural Experiment","OPTIMIZEDOAC","Inclusion Criteria:\n\n* Isolated hip fracture classified as AO\u002FOTA 31A or 31B requiring surgical intervention.\n* Current DOAC use with the last dose taken ≤24 hours before emergency department (ED) presentation\n\nExclusion Criteria:\n\n* Pathologic or periprosthetic hip fractures.\n* Fracture sustained \\>24 hours before ED presentation.\n* Inter-hospital transfer.\n* Hematologic disorders (e.g., thalassemia, sickle cell disease, aplastic anemia, myelodysplastic syndromes, leukemia).\n* Use of a non-EMA-approved DOAC (e.g., betrixaban).",{"count":177,"type":21},374,"This study looks at patients with hip fractures who are taking direct oral anticoagulants (DOACs), a type of blood thinner. In many hospitals, surgery for these patients is delayed because of concerns about bleeding, but waiting longer can also increase risks such as complications and longer hospital stays. The purpose of this study is to find out whether operating within 24 hours is as safe as delaying surgery beyond 24 hours. Specifically, the investigators want to know if early surgery does not lead to a higher need for blood transfusions compared to delayed surgery.",[28,180,181,182,183,184,185,186,187],"Hip Fracture Surgeries","Geriatric","Bleeding Complications","Bleeding as Surgical Complication (Treatment)","Bleeding","Blood Transfusions","Blood Transfusion Complication","Direct Oral Anticoagulants (DOACs)",[189,190,191,192,193,194,195,196,197,198],"natural experiment","doac","direct oral anticoagulant","hip fracture","geriatric","surgery","bleeding","blood transfusion","early","delayed","2025-12-15",{"date":201,"type":41},"2025-12-30",{"date":203,"type":41},"2025-11-01",{"date":205,"type":21},"2027-12-31",{"name":207,"class":48},"St. Antonius Hospital",7,{"id":210,"slug":211,"hasResults":11,"nctId":212,"briefTitle":213,"officialTitle":214,"acronym":215,"eligibilityCriteria":216,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":217,"targetDuration":4,"studyType":22,"phases":219,"briefSummary":220,"conditions":221,"keywords":223,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":230,"lastUpdatePostDateStruct":231,"startDateStruct":233,"completionDateStruct":235,"leadSponsor":237,"locationsCount":49},"100571298","hemoglobin-levels-for-blood-transfusions-during-and-after-surgery-100571298","NCT06718439","Hemoglobin Levels for Blood Transfusions During and After Surgery","Threshold for Operative and Postoperative Hemoglobin Trigger for Red Blood Cell Transfusion: A Pilot Randomized Controlled Trial (TOPGUN-Pilot)","TOPGUN-Pilot","Inclusion Criteria:\n\n* Adult patients, age ≥18.\n* Elective or urgent surgery.\n* Risk of red blood cell transfusion of at least 10 percent.\n* Preoperative hemoglobin of less than 130 g\u002FL.\n* Intraoperative hemoglobin of ≤ 100 g\u002FL at any time during surgery.\n\nExclusion Criteria:\n\n* Active major hemorrhage as indication for surgery (e.g. ruptured aneurysm, polytrauma, etc.).\n* Acute coronary syndrome or myocardial infarction within the past 6 weeks.\n* Cardiac surgery.\n* Liver transplantation.\n* Surgery for moderate to severe (Glasgow Coma Scale (GCS) score ≤ 12) traumatic brain injury.\n* Pregnancy or obstetrical surgery.\n* Patient refusal of blood products.\n* Inability to provide consent.",{"count":218,"type":21},384,[24],"The goal of this pilot clinical trial is to learn if it is achievable to conduct a large-scale clinical trial whereby, the investigators will compare two ways of deciding when to give a blood transfusion during surgery. Participants in this study are adults undergoing surgery with a risk of significant blood loss.\n\nThe main question it aims to answer is:\n\n* Is a trial designed to definitively test and compare two different red blood cell transfusion strategies feasible?\n\nParticipants will:\n\n* Receive blood transfusions during surgery based on a higher (less than 90 g\u002FL) or a lower (less than 70 g\u002FL) hemoglobin value.\n* Complete questionnaires at 30 and 90 days after surgery.",[28,222],"Surgery",[224,225,226,227,228,229],"Red blood cell transfusion","hemoglobin threshold","blood loss management","liberal transfusion practice","restrictive transfusion practice","intraoperative","2025-07-29",{"date":232,"type":41},"2025-07-31",{"date":234,"type":41},"2025-04-16",{"date":236,"type":21},"2027-01-15",{"name":238,"class":48},"Ottawa Hospital Research Institute",{"id":240,"slug":241,"hasResults":11,"nctId":242,"briefTitle":243,"officialTitle":244,"acronym":4,"eligibilityCriteria":245,"healthyVolunteers":11,"sex":17,"minAge":246,"maxAge":247,"enrollmentInfo":248,"targetDuration":4,"studyType":22,"phases":250,"briefSummary":252,"conditions":253,"keywords":258,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":266,"lastUpdatePostDateStruct":267,"startDateStruct":268,"completionDateStruct":270,"leadSponsor":272,"locationsCount":49},"100420079","phase-3-management-of-shock-in-children-with-sam-or-severe-underweight-and-diarrhea-100420079","NCT04750070","Management of Shock in Children With SAM or Severe Underweight and Diarrhea","Randomized Controlled Trial of Dopamine, Adrenaline, and Blood Transfusion for Treatment of Fluid Refractory Shock in Children With Severe Acute Malnutrition or Severe Underweight and Cholera or Other Dehydrating Diarrheas","Inclusion Criteria:\n\n1. Children of either sex with acute malnutrition and diarrhea\n2. Age: 1-59 months\n3. Children with cerebral palsy (CP) and\u002For developmental delay, Down Syndrome with or without heart diseases\n4. Fluid refractory shock\n5. Consent from the caregivers\u002Fparents\n\nExclusion Criteria:\n\n1. Having a rare blood group (Rh negative blood groups provided that donor is not available)\n2. A child requiring cardio-pulmonary resuscitation during screening or having gasping respiration","1 Month","59 Months",{"count":249,"type":21},135,[251],"PHASE3","Diarrhea is one of the leading causes of under-five childhood mortality and accounts for 8% of 5.4 million global under-5 deaths. The coexistence of sepsis and hypovolemic shock in children with severe acute malnutrition (SAM) having diarrhea is common. At Dhaka hospital of icddr,b, the death rate is as high as 40% and 69% in children with severe sepsis and septic shock respectively with co-morbidities such as severe malnutrition.\n\nThe conventional management of SAM children with features of severe sepsis recommended by WHO includes administration of boluses of isotonic saline followed by blood transfusion in unresponsive cases with septic shock; whereas the Surviving Sepsis Campaign (SSC) guideline recommends vasoactive support. To date, no study has evaluated systematically the effects of inotrope(s) and vasopressor or blood transfusion in children with dehydrating diarrhea (for example, in cholera) and SAM having shock and unresponsive to WHO standard fluid therapy.\n\nThis randomized trial will generate evidence whether inotrope and vasopressor or blood transfusion should be selected for severely malnourished children having hypotensive shock and who failed to respond to WHO standard fluid bolus.",[254,255,28,256,257],"Shock Hypovolemic","Shock, Septic","Adrenaline","Dopamine",[259,260,261,262,263,264,265],"Severe acute malnutrition","Children","Shock","Cholera","Dehydrating diarrhea","Severe underweight","Acute malnutrition","2025-04-13",{"date":234,"type":41},{"date":269,"type":41},"2021-08-17",{"date":271,"type":21},"2025-11-30",{"name":273,"class":48},"International Centre for Diarrhoeal Disease Research, Bangladesh",{"id":275,"slug":276,"hasResults":11,"nctId":277,"briefTitle":278,"officialTitle":279,"acronym":4,"eligibilityCriteria":280,"healthyVolunteers":82,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":281,"targetDuration":4,"studyType":22,"phases":283,"briefSummary":284,"conditions":285,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":291,"lastUpdatePostDateStruct":292,"startDateStruct":294,"completionDateStruct":296,"leadSponsor":298,"locationsCount":49},"100519915","d2-versus-d3-dissection-in-laparoscopic-right-hemicolectomy-100519915","NCT06049758","D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy","D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy In Right Cancer Colon Patients: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients with right-side colon cancer (caecum, ascending, or hepatic flexure)\n* Diagnosed by CT entero-colonography\n* Diagnosed by colonoscopy\n* Diagnosed by biopsy.\n\nExclusion Criteria:\n\n* Emergency surgery (obstruction, perforation with generalized peritonitis),\n* Metastatic tumor diagnosed\n* ASA score of IV or higher\n* Need for more than one surgical procedure\n* Conversion to open surgery",{"count":282,"type":21},80,[24],"Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-operative ICU admission, anastomotic leakage, lymph node harvesting in the final specimen, and six months follow up and overall survival time after 5-years",[286,287,288,289,290,28],"Blood Loss","Intensive Care","Anastomotic Leakage","Lymph Node Disease","Survival","2023-09-19",{"date":293,"type":41},"2023-09-22",{"date":295,"type":21},"2024-01-02",{"date":297,"type":21},"2030-01-02",{"name":299,"class":101},"General Committee of Teaching Hospitals and Institutes, Egypt"]